|
|
|
|
Am J Clin Nutr 2010,Jul,01;92(1):244-51; (PMID: 20484456)
[...]BACKGROUND: Consumption of fish and n-3 (omega-3) long-chain polyunsaturated fatty acids (LCPUFAs) has been associated with reduced risk of coronary artery disease (CAD) mortality. OBJECTIVE: The aim was to examine the relation between dietary intake[...]
|
|
|
Am J Cardiol 2010,Jun,01;105(11):1577-84; (PMID: 20494665)
Total plasma homocysteine (tHcy) is an independent risk factor for coronary artery disease, and tHcy is lowered by B vitamins. To assess the effect of homocysteine[...]
|
|
|
Eur J Clin Nutr 2010,May,01;64(5):495-502; (PMID: 20216560) [FULL TEXT AVAILABLE]
[...], which may influence fetal growth, risk of type II diabetes and cardiovascular disease. The purpose of this paper was to study the effect of physiological doses of B(12) and [...]
|
|
|
Indian J Dermatol Venereol Leprol 2010,Mar,01;76(2):103-15; (PMID: 20228538)
[...] about what foods to consume, and what to avoid, in the hope that, no matter how impractical or difficult this may be, following this dictum will cure their disease. There are certain disorders where one or more components in food are central to the pathogenesis, e.g. [...], genetic and metabolic disorders (phenylketonuria, tyrosinemia, homocystinuria, galactosemia, Refsum's disease, G6PD deficiency, xanthomas, gout and porphyria), nutritional deficiency disorders (kwashiorkar, marasmus[...]
|
|
|
Int J Geriatr Psychiatry 2010,Jan,01;25(1):82-90; (PMID: 19484711)
[...]OBJECTIVE: Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of [...]
|
|
|
JAMA 2009,Nov,18;302(19):2119-26; (PMID: 19920236)
[...]-controlled clinical trials (Norwegian Vitamin Trial and Western Norway B Vitamin Intervention Trial). A total of 6837 patients with ischemic heart disease were treated with B vitamins or placebo between 1998 and 2005, and were followed up through December 31, 2007.[...]
|
|
|
Neurobiol Dis 2009,Nov,01;36(2):401-10; (PMID: 19703563)
[...] are branched-chain fatty acids, which play an important role in diseases with peroxisomal impairment, like Refsum disease (MIM 266500), Zellwegers syndrome and alpha-methylacyl-CoA racemase deficiency (MIM 604489). Several studies revealed that the toxic activity of [...]
|
|
|
Can J Neurol Sci 2009,Jul,01;36(4):409-28; (PMID: 19650351)
[...]ataxia, ataxia due to vitamin E deficiency, ataxia due to Abeta-lipoproteinemia, Refsum disease, late-onset Tay-Sachs disease, cerebrotendineous xanthomatosis, spinocerebellar ataxia with axonal neuropathy, ataxia[...]
|
|
|
Ophthalmologe 2009,Jul,01;106(7):639-45; (PMID: 19572133)
[...]The formation, development and external impact of the following eight disease-specific patient groups with rare forms of retinal degeneration (RRD) within the patient organization Pro [...] organization Pro Retina are described: Gyrate Atrophy, Bardet-Biedl Syndrome (BBS), Adult Refsum's Disease, Usher Syndrome, Rod-Cone Dystrophy, Leber's Congenital Amaurosis, Choroideremia and Stargardt Disease[...]
|
|
|
Circulation 2009,May,12;119(18):2507-15; (PMID: 19398669)
BACKGROUND: The role of circulating homocysteine as an atherosclerosis risk factor has recently been questioned. However, 5-methyl-tetrahydrofolate (5-MTHF), the circulating metabolite of folic acid participating in homocysteine metabolism[...]
|
 1 2 3 4 5 6 7 8 
|
|
